Anesthesia Drugs Market Analysis

Drugs (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam)

The propofol segment is estimated to hold 36% share of the global anesthesia drugs market by 2037. Among the most widely used general anesthetics for surgeries, propofol is also utilized as a sedative in the intensive care unit (ICU) for patients in critical care, particularly those with COVID-19. It is employed in the beginning and continuation of general anesthesia, procedural sedation, etc.

The use of Fresenius Propoven 2% emulsion to sustain sedation in COVID-19 patients in need of mechanical breathing was approved by the US Food and Drug Administration in June 2020. Its lipophilic nature and quick onset of action with little adverse effects make it a popular choice for surgical procedures. Anesthesiologists frequently employ propofol, together with anxiolytics and analgesics, to promote sleep while allowing patients to continue breathing on their own at lower dosages. Additionally, refractory-grade epileptics can be treated with propofol. In adult patients, propofol is often used in ventilation-based sedation procedures when other drugs are not working. Furthermore, in the intensive care unit (ICU), propofol is utilized as a primary anesthetic to provide patients with deep drowsiness while they are hooked up to ventilators.

Application (Plastic Surgeries, Cosmetic Surgeries, General Surgeries, Dental Surgeries, Gynaecology Surgeries)

Based on application, the general surgeries segment in the anesthesia drugs market is predicted to hold the largest revenue share of about 30% during the projection period. Over the projected period, a large growth in the market will be seen. The market is being pushed by the number of surgeries rising, the population being older and having more chronic illnesses, and improvements in anesthesia technology. According to data from the American Society of Plastic Surgeons (ASPS), 16.3 million cosmetic minimally invasive treatments and around 1.8 million cosmetic surgical operations were carried out in the US in 2019.

Our in-depth analysis of the anesthesia drugs market includes the following segments: